Lithium Ion

Lithium Ion

SCHEMBL31722606

COC(OC)C1CCN(c2ccc(C(=O)[O-])nc2)CC1.[Li+]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 9/20 0.45
▸ MAPT P10636 4/20 0.35
▸ ACACB O00763 2/20 0.34
▸ ACKR3 P25106 1/20 0.34
▸ CHRNB2 P17787 2/20 0.34
▸ CHRNB4 P30926 2/20 0.34
▸ CHRNA3 P32297 2/20 0.34
▸ CHRNA4 P43681 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TRPC6 Q9Y210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31722347 0.86 HRH3 (0.59) HRH3MAPTACACBACKR3NPC1
SCHEMBL30723925 0.78 CHRNB2 (0.53) HRH3MAPTCHRNB2CHRNB4CHRNA3
SCHEMBL27042090 0.77 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL31607811 0.77 TRPC6 (0.39) HRH3CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL26641428 0.77 TRPC6 (0.39) HRH3CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL31607877 0.77 MAPT (0.62) HRH3MAPTCHRNB2CHRNB4CHRNA3
SCHEMBL26641388 0.77 MAPT (0.62) HRH3MAPTCHRNB2CHRNB4CHRNA3
Lithium Ion SCHEMBL20163088 0.76 HDAC3 (0.49) MAPTNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL30963410 0.74 CRBN (0.51) HRH3
SCHEMBL31198943 0.73 HRH3 (0.52) HRH3MAPTACACBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025228947-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF INDUCING DEGRADATION OF POLO-LIKE KINASE1 CROSSFIRE ONCOLOGY B.V. (NL) 2025-11-06 — — WO disclosed
Send feedback